{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:32:28Z","timestamp":1790163148209,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.neuropharm.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T19:23:31Z","timestamp":1238441011000},"page":"1116-1123","source":"Crossref","is-referenced-by-count":67,"title":["Cocaine-induced hyperactivity and sensitization are dependent on GSK3"],"prefix":"10.1016","volume":"56","author":[{"given":"Jonathan S.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Unterwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2009.03.006_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(25)20979-X","article-title":"Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference","volume":"279","author":"Baker","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2004.01.016","article-title":"Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials","volume":"70","author":"Basan","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib3","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.271.12.918","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania. The depakote mania study group","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1124\/mol.107.034942","article-title":"Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons","volume":"72","author":"Chen","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neurobiolaging.2005.03.003","article-title":"In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors","volume":"27","author":"De Sarno","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0006-2952(75)90152-5","article-title":"Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices","volume":"24","author":"Heikkila","year":"1975","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.2.5919.584","article-title":"Sodium valproate in treatment of epilepsy","volume":"2","author":"Jeavons","year":"1974","journal-title":"British Medical Journal"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)22646-5","article-title":"Behavioral and neurochemical effects of acute and daily cocaine administration in rats","volume":"245","author":"Kalivas","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.tpj.6500269","article-title":"Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons","volume":"4","author":"Kanai","year":"2004","journal-title":"The Pharmacogenomics Journal"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(89)90045-3","article-title":"Blockade of \u201creverse tolerance\u201d to cocaine and amphetamine by MK-801","volume":"45","author":"Karler","year":"1989","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02245070","article-title":"Cocaine behavioral sensitization and the excitatory amino acids","volume":"115","author":"Karler","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-008-1165-0","article-title":"Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization","volume":"200","author":"Karlsson","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/45790","article-title":"Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine","volume":"401","author":"Kelz","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0891-0618(99)00012-5","article-title":"Developmental expression and localization of glycogen synthase kinase-3beta in rat brain","volume":"16","author":"Leroy","year":"1999","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2005.01.015","article-title":"Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice","volume":"161","author":"Li","year":"2005","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0028-3908(93)90161-U","article-title":"Cocaine-induced behaviour: dopamine D1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine","volume":"32","author":"McCreary","year":"1993","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.neuropharm.2009.03.006_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2004.06.031","article-title":"Molecular mechanisms of drug addiction","volume":"47","author":"Nestler","year":"2004","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.neuropharm.2009.03.006_bib32","first-page":"17","article-title":"Pharmacology of valproate","volume":"37","author":"Owens","year":"2003","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib33","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1523\/JNEUROSCI.16-04-01550.1996","article-title":"Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization","volume":"16","author":"Pierce","year":"1996","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/260731a0","article-title":"Increasing effects of repetitive cocaine administration in the rat","volume":"260","author":"Post","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib36","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","article-title":"Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania","volume":"26","author":"Prickaerts","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Research Brain Research Reviews"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2004.10.039","article-title":"Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine","volume":"57","author":"Roh","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib39","doi-asserted-by":"crossref","first-page":"37526","DOI":"10.1074\/jbc.M502699200","article-title":"A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons","volume":"280","author":"Szatmari","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib40","series-title":"Drug Synergism and Dose\u2013Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(00)02996-6","article-title":"Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats","volume":"887","author":"Yang","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2009.03.006_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(00)02500-2","article-title":"Valproate modulates the expression of methylphenidate (ritalin) sensitization","volume":"874","author":"Yang","year":"2000","journal-title":"Brain Research"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T19:07:31Z","timestamp":1739041651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390809000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0028390809000835"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2009.03.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}